We have previously shown that Staphylococcus aureus Cowan immunoglobulin secretion in normal B cells can be substistrain 1 particles (SAC) ؉ thioredoxin (Trx) ؉ IL-2 may induce tuted by 9 IL-15 has no effect on normal resting B cells, 
Introduction

B-CLL cells B-chronic lymphocytic leukemia (B-CLL) is the most common leukemia among adults in the Western countries. 1 B-CLL is
The clinical staging, status of treatment and laboratory paracharacterized by an accumulation of CD5-positive leukemic meters for 12 B-CLL patients are shown in Table 1 . B-CLL B cells in peripheral blood (PB) and lymphoid organs. B-CLL cells were collected from peripheral blood (PB) and isolated is clinically a heterogeneous disease, both in cellular phenoon Ficoll-Paque (Pharmacia, Uppsala, Sweden) density graditype and state of proliferation.
1 Although B-CLL cells can be ent centrifugation, and stored in liquid nitrogen. Due to the induced to proliferate and differentiate in vitro using different well known heterogeneous response of different B-CLL clones protocols of stimulation 2,3 the response will vary between to in vitro stimulation, and in order to obtain reproducible individual patient samples. The most efficient protocol for induction of proliferation, so far, has been the combination of Staphylococcus aureus Cowan strain 1 (SAC) particles + thioredoxin (Trx) + IL-2, that results in increased DNA synthesis and a complete transition of the cells through the cell cycle with a subsequent cell cycle arrest in G 1 . 4 The presence of Trx is essential for the SAC + IL-2-induced DNA synthesis of B-CLL cells. 4 The induced proliferation is independent of contaminating T cells and monocytes. 4 In a recent study we have examined the effect of IL-2 + Trx on the induction of proliferation in B-CLL cells and found that these cells may be induced to proliferate even without preactivation with SAC particles. In addition, both IL-2 + Trx and SAC + IL-2 + Trx-induced proliferation were inhibited by an anti-CD40 mAb. 30 In these aspects B-CLL cells differ from normal B cells.
Recently, a new interleukin, IL-15, was identified. IL-15 shows similarities in function to IL-2 and binds to IL-2R␤ and IL-2R␥ 5, 6 and also to its newly cloned receptor, the IL-15R␣.
7,8
The expression of IL-15 is most abundant in skeletal muscle, placenta and activated monocytes/macrophages. 18 at a final concentration of San Jose, CA, USA) using anti-CD3, anti-CD5, anti-CD14, 1 g/ml. anti-CD19 and anti-CD20 mAb (Dako, Glostrup, Denmark) ( Table 2 ).
Expression and blocking experiments of IL-2R␣ and IL-2R␤ Normal B cells Peripheral mononuclear cells were isolated from PB of five IL-2R␣ and IL-2R␤ expression was determined by flow cytometry using anti-IL-2R␤ (anti-TIC) and anti-IL-2R␣ (anti-TAC) healthy donors and from two umbilical cord blood (CB) by Ficoll-Paque density gradient centrifugation. PB and CB cells mAb (a kind gift of K Smith, Dartmouth Medical School, Hannover, NH, USA). Anti-TSH mAb was used as a negative were incubated with anti-CD19-coated magnetic beads (Dynal, Oslo, Norway) at 4°C, and B cells were separated with control. The same mAbs were used in the blocking experi- The purity of the B-CLL samples was determined by flow cytometry. The percentage of B-CLL cells, T cells and monocytes in the different samples is presented. ment, in which mAbs were supplemented to the media at different concentrations.
Measurement of induced growth and differentiation
The DNA synthesis was determined by incubating cells in triplicate 0.2 ml cultures with 1 Ci of 3 H-TdR (specific activity 25 Ci/mmol; Amersham) for the last 24 h of the culture period. The cell cycle analyses were performed as described. Briefly, the cells were washed in cold PBS, lysed in NP40 of the PB-B cells from the three donors responded with significant DNA synthesis to any of the combinations. buffer, treated with trypsin (0.03 mg/ml), trypsin inhibitor
The response of B-CLL cells and normal B cells appears to (0.5 mg/ml), ribonuclease A (0.1 mg/ml) (Sigma, St Louis, MO, differ with respect to IL-15 + Trx-induced proliferation. To USA) and were then exposed to propidium iodide (0.416 determine whether this difference was a malignancy-associamg/ml, Calbiochem, San Diego, CA, USA). The stained nuclei ted characteristic of B-CLL cells we cultured five normal PBwere analyzed by flow cytometry. we investigated the effects of IL-15 + Trx in the induction of proliferation in B-CLL cells. We show here that IL-15 + Trx factor production. 25, 26 These differences might, however, only reflect the difference in the cell ratio, B-CLL cells vs accessory are able to induce proliferation in some of the B-CLL clones without any preactivation, although the DNA synthesis was cells, compared to the normal situation.
27
Further studies on the production of IL-2 and IL-15 in vivo enhanced by the addition of SAC particles. We have previously found that IL-2-induced proliferation of B-CLL cells in patients with B-CLL in different stages of the disease, and studies in vitro, on the interaction between B-CLL cells and T is dependent on the presence of Trx. 30 As with IL-2-induced proliferation we also found that IL-15-induced proliferation cells and monocyte-derived cells are needed to clarify the role of IL-2 and IL-15 in the pathogenesis of B-CLL. was dependent on the presence of Trx.
In with soluble CD40L. 30 We here report that IL-15 + Trx-5 Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, induced proliferation is also inhibited when they are cultured 
